Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Su-Ann Yeoh ,Jean W Liew ,Milena Gianfrancesco ,Philip C Robinson ,Reinhard Voll ,Zachary S Wallace ,Christophe Richez ,Guillermo J Pons‐Estel ,Lindsay Jacobsohn ,E Velozo ,Elsa F Mateus ,Arundathi Jayatilleke ,Sofía Ornella ,Laure Gossec ,Kristin M D’silva ,Loreto Carmona ,Laurindo Ferreira Da Rocha ,Martin Schäfer ,Monica Vasquez Del Mercado ,Rebecca Grainger ,Paul Sufka ,J Hausmann ,Paula Jordan ,Suleman Bhana ,É Hachulla ,Kimme L Hyrich ,Samuel Katsuyuki Shinjo ,Monique Gore-Massy ,Hanns‐Martin Lorenz ,Tiffany Hsu ,Emily Sirotich ,Marie Holmqvist ,Edgard Torres Dos Reis Neto ,Víctor R Pimentel-Quiroz ,Anja Strangfeld ,Maria Eugenia D’angelo Exeni ,Jinoos Yazdany ,Ana Carolina De Oliveira E Silva Montandon ,Saskia Lawson‐Tovey ,Rebecca Hasseli ,Ca Scirè ,Pedro Machado

doi:10.1136/rmdopen-2022-002508

Abstract

ObjectivesTo investigate factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy (IIM).MethodsDemographic data, clinical characteristics and COVID-19 outcome severity of adults with IIM were obtained from the COVID-19...

Full Text